154 related articles for article (PubMed ID: 33625849)
21. CIGAR-seq, a CRISPR/Cas-based method for unbiased screening of novel mRNA modification regulators.
Fang L; Wang W; Li G; Zhang L; Li J; Gan D; Yang J; Tang Y; Ding Z; Zhang M; Zhang W; Deng D; Song Z; Zhu Q; Cui H; Hu Y; Chen W
Mol Syst Biol; 2020 Nov; 16(11):e10025. PubMed ID: 33251765
[TBL] [Abstract][Full Text] [Related]
22. A Novel Screening Approach for the Dissection of Cellular Regulatory Networks of NF-κB Using Arrayed CRISPR gRNA Libraries.
O'Shea P; Wildenhain J; Leveridge M; Revankar C; Yang JP; Bradley J; Firth M; Pilling J; Piper D; Chesnut J; Isherwood B
SLAS Discov; 2020 Jul; 25(6):618-633. PubMed ID: 32476557
[TBL] [Abstract][Full Text] [Related]
23. A Perspective on the Future of High-Throughput RNAi Screening: Will CRISPR Cut Out the Competition or Can RNAi Help Guide the Way?
Taylor J; Woodcock S
J Biomol Screen; 2015 Sep; 20(8):1040-51. PubMed ID: 26048892
[TBL] [Abstract][Full Text] [Related]
24. Combinatorial genetics in liver repopulation and carcinogenesis with a in vivo CRISPR activation platform.
Wangensteen KJ; Wang YJ; Dou Z; Wang AW; Mosleh-Shirazi E; Horlbeck MA; Gilbert LA; Weissman JS; Berger SL; Kaestner KH
Hepatology; 2018 Aug; 68(2):663-676. PubMed ID: 29091290
[TBL] [Abstract][Full Text] [Related]
25. Theophylline-induced synergic activation of guide RNA to control CRISPR/Cas9 function.
Liu Y; Wang Y; Lin J; Xu L
Chem Commun (Camb); 2021 Jun; 57(44):5418-5421. PubMed ID: 33949481
[TBL] [Abstract][Full Text] [Related]
26. Improving the specificity and efficacy of CRISPR/CAS9 and gRNA through target specific DNA reporter.
Zhang JH; Pandey M; Kahler JF; Loshakov A; Harris B; Dagur PK; Mo YY; Simonds WF
J Biotechnol; 2014 Nov; 189():1-8. PubMed ID: 25193712
[TBL] [Abstract][Full Text] [Related]
27. A genome-wide analysis of Cas9 binding specificity using ChIP-seq and targeted sequence capture.
O'Geen H; Henry IM; Bhakta MS; Meckler JF; Segal DJ
Nucleic Acids Res; 2015 Mar; 43(6):3389-404. PubMed ID: 25712100
[TBL] [Abstract][Full Text] [Related]
28. CRISPR Guide RNA Cloning for Mammalian Systems.
Nageshwaran S; Chavez A; Cher Yeo N; Guo X; Lance-Byrne A; Tung A; Collins JJ; Church GM
J Vis Exp; 2018 Oct; (140):. PubMed ID: 30346403
[TBL] [Abstract][Full Text] [Related]
29. CRISPR multitargeter: a web tool to find common and unique CRISPR single guide RNA targets in a set of similar sequences.
Prykhozhij SV; Rajan V; Gaston D; Berman JN
PLoS One; 2015; 10(3):e0119372. PubMed ID: 25742428
[TBL] [Abstract][Full Text] [Related]
30. Multiplex Generation, Tracking, and Functional Screening of Substitution Mutants Using a CRISPR/Retron System.
Lim H; Jun S; Park M; Lim J; Jeong J; Lee JH; Bang D
ACS Synth Biol; 2020 May; 9(5):1003-1009. PubMed ID: 32348672
[TBL] [Abstract][Full Text] [Related]
31. CRISPR-TAPE: protein-centric CRISPR guide design for targeted proteome engineering.
Anderson DP; Benns HJ; Tate EW; Child MA
Mol Syst Biol; 2020 Jun; 16(6):e9475. PubMed ID: 32485092
[TBL] [Abstract][Full Text] [Related]
32. Large-scale reconstruction of cell lineages using single-cell readout of transcriptomes and CRISPR-Cas9 barcodes by scGESTALT.
Raj B; Gagnon JA; Schier AF
Nat Protoc; 2018 Nov; 13(11):2685-2713. PubMed ID: 30353175
[TBL] [Abstract][Full Text] [Related]
33. Targeted Perturb-seq enables genome-scale genetic screens in single cells.
Schraivogel D; Gschwind AR; Milbank JH; Leonce DR; Jakob P; Mathur L; Korbel JO; Merten CA; Velten L; Steinmetz LM
Nat Methods; 2020 Jun; 17(6):629-635. PubMed ID: 32483332
[TBL] [Abstract][Full Text] [Related]
34. CRISPR as a Diagnostic Tool.
Kim S; Ji S; Koh HR
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439828
[TBL] [Abstract][Full Text] [Related]
35. Single-cell characterization of CRISPR-modified transcript isoforms with nanopore sequencing.
Kim HS; Grimes SM; Hooker AC; Lau BT; Ji HP
Genome Biol; 2021 Dec; 22(1):331. PubMed ID: 34872615
[TBL] [Abstract][Full Text] [Related]
36. Broad-Spectrum and Personalized Guide RNAs for CRISPR/Cas9 HIV-1 Therapeutics.
Dampier W; Sullivan NT; Mell JC; Pirrone V; Ehrlich GD; Chung CH; Allen AG; DeSimone M; Zhong W; Kercher K; Passic S; Williams JW; Szep Z; Khalili K; Jacobson JM; Nonnemacher MR; Wigdahl B
AIDS Res Hum Retroviruses; 2018 Nov; 34(11):950-960. PubMed ID: 29968495
[TBL] [Abstract][Full Text] [Related]
37. CRISPR Guide RNA Design Guidelines for Efficient Genome Editing.
Schindele P; Wolter F; Puchta H
Methods Mol Biol; 2020; 2166():331-342. PubMed ID: 32710418
[TBL] [Abstract][Full Text] [Related]
38. scDecouple: decoupling cellular response from infected proportion bias in scCRISPR-seq.
Meng Q; Wei L; Ma K; Shi M; Lin X; Ho JWK; Li Y; Zhang X
Brief Bioinform; 2024 Jan; 25(2):. PubMed ID: 38324621
[TBL] [Abstract][Full Text] [Related]
39. Efficient genetic manipulation of the NOD-Rag1-/-IL2RgammaC-null mouse by combining in vitro fertilization and CRISPR/Cas9 technology.
Li F; Cowley DO; Banner D; Holle E; Zhang L; Su L
Sci Rep; 2014 Jun; 4():5290. PubMed ID: 24936832
[TBL] [Abstract][Full Text] [Related]
40. Functional Evaluation of CRISPR Activity by the Dual-Fluorescent Surrogate System: C-Check.
Lin L; Luo Y
Methods Mol Biol; 2019; 1961():67-77. PubMed ID: 30912040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
